LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1922

Search options

  1. Article: [Effect of jian yan ling on serum lipids, apoprotein and lipoprotein-a].

    Lu, D C / Su, Z J / Rui, T

    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine

    1994  Volume 14, Issue 3, Page(s) 142–4, 131–2

    Abstract: Effect of Jian Yan Ling (JYL, mainly consisted of Succinum, Pteria margaritifers and ...

    Abstract Effect of Jian Yan Ling (JYL, mainly consisted of Succinum, Pteria margaritifers and Astragalus membranaceus etc.) on serum lipids was studied by double-blind method in 128 hyperlipemia patients. Patients were divided randomly into two groups, the test groups (64 cases) treated with JYL, while the other 64 cases treated with placebo as control for 3 months. Serum total cholesterol (TC), triglyceride (TG), TC-high density lipolipid-cholesterol (TC-HDL-C), apoproteins were observed before and after treatment. Results showed that the TC, TG, apoproteins and lipoprotein-a of test group were all dropped significantly after JYL treatment (P < 0.01). The results suggested that JYL could regulate the blood lipids and could also exert an effect of antiatherosclerosis through reducing blood lipoprotein-a level. It is worth while to use JYL as an antihyperlipemic agent clinically.
    MeSH term(s) Apolipoproteins A/metabolism ; Apolipoproteins B/metabolism ; Astragalus membranaceus ; Capsules ; Cholesterol/blood ; Cholesterol, HDL/blood ; Double-Blind Method ; Drugs, Chinese Herbal/therapeutic use ; Female ; Humans ; Hyperlipidemias/blood ; Hyperlipidemias/drug therapy ; Hypolipidemic Agents/therapeutic use ; Lipoprotein(a)/blood ; Male ; Middle Aged ; Triglycerides/blood
    Chemical Substances Apolipoproteins A ; Apolipoproteins B ; Capsules ; Cholesterol, HDL ; Drugs, Chinese Herbal ; Hypolipidemic Agents ; Lipoprotein(a) ; Triglycerides ; Cholesterol (97C5T2UQ7J)
    Language Chinese
    Publishing date 1994-03
    Publishing country China
    Document type Clinical Trial ; Journal Article ; Randomized Controlled Trial
    ZDB-ID 1195456-5
    ISSN 1003-5370
    ISSN 1003-5370
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Myelodysplastic syndrome-like response after voriconazole treatment of systemic lupus erythematosus complicated with fungal infection: a case report.

    Xie, Guang-Liang / Wang, Xiao-Su / Hu, Ling-Yan / Wang, Yi / Gu, Xiangchen / Xu, Yan-Qiu

    Frontiers in medicine

    2023  Volume 10, Page(s) 1286649

    Abstract: Background: Voriconazole is mainly used to treat progressive and potentially life-threatening infections in immunocompromised patients. The adverse drug reactions related to voriconazole are varied. In some rare cases, the use of voriconazole can result ...

    Abstract Background: Voriconazole is mainly used to treat progressive and potentially life-threatening infections in immunocompromised patients. The adverse drug reactions related to voriconazole are varied. In some rare cases, the use of voriconazole can result in myelodysplastic syndrome (MDS)-like adverse reactions.
    Case presentation: Here, we present a rare case of systemic lupus erythematosus patient with a fungal infection that developed MDS-like adverse reactions after treatment with voriconazole. The patient was admitted to the hospital because of 3 days of chest tightness and dyspnea. After the admission, the patient's sputum culture showed
    Conclusion: This case reminded us that when using voriconazole for treatment, individual differences in patients should be considered, and the blood concentration of voriconazole should be closely monitored. Otherwise, potential drugs that affect voriconazole metabolism should be noted, and related adverse symptoms of patients should be closely observed during medication to reduce the occurrence of adverse drug events.
    Language English
    Publishing date 2023-12-07
    Publishing country Switzerland
    Document type Case Reports
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2023.1286649
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Co-production of xylooligosaccharides and glucose from birch sawdust by hot water pretreatment and enzymatic hydrolysis.

    Fang, Lingyan / Su, Yan / Wang, Peng / Lai, Chenhuan / Huang, Caoxing / Ling, Zhe / Yong, Qiang

    Bioresource technology

    2022  Volume 348, Page(s) 126795

    Abstract: A green method for co-production of value-added xylooligosaccharides (XOS) and glucose from birch was demonstrated using hot water pretreatment. Effects of pretreatment severity factor (Log ... ...

    Abstract A green method for co-production of value-added xylooligosaccharides (XOS) and glucose from birch was demonstrated using hot water pretreatment. Effects of pretreatment severity factor (Log R
    MeSH term(s) Betula ; Glucose ; Glucuronates ; Hydrolysis ; Oligosaccharides ; Water
    Chemical Substances Glucuronates ; Oligosaccharides ; xylooligosaccharide ; Water (059QF0KO0R) ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2022-02-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 1065195-0
    ISSN 1873-2976 ; 0960-8524
    ISSN (online) 1873-2976
    ISSN 0960-8524
    DOI 10.1016/j.biortech.2022.126795
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Myelodysplastic syndrome-like response after voriconazole treatment of systemic lupus erythematosus complicated with fungal infection

    Guang-Liang Xie / Xiao-Su Wang / Ling-Yan Hu / Yi Wang / Xiangchen Gu / Yan-Qiu Xu

    Frontiers in Medicine, Vol

    a case report

    2023  Volume 10

    Abstract: BackgroundVoriconazole is mainly used to treat progressive and potentially life-threatening infections in immunocompromised patients. The adverse drug reactions related to voriconazole are varied. In some rare cases, the use of voriconazole can result in ...

    Abstract BackgroundVoriconazole is mainly used to treat progressive and potentially life-threatening infections in immunocompromised patients. The adverse drug reactions related to voriconazole are varied. In some rare cases, the use of voriconazole can result in myelodysplastic syndrome (MDS)-like adverse reactions.Case presentationHere, we present a rare case of systemic lupus erythematosus patient with a fungal infection that developed MDS-like adverse reactions after treatment with voriconazole. The patient was admitted to the hospital because of 3 days of chest tightness and dyspnea. After the admission, the patient’s sputum culture showed Candida albicans infection, and voriconazole was prescribed to be taken orally. After using voriconazole, drug-related adverse reactions such as visual impairment, nausea, vomiting, hiccup, middle and lower abdominal pain, disorders of consciousness, delirium, hallucination, slow response, and subcutaneous ecchymosis appeared, as well as the gradually increased serum creatinine, oliguria, and aggravated lower limb edema. In addition, there was a decrease in peripheral blood cells, and MDS-like changes in bone marrow were indicated by bone marrow biopsy. After discontinuing voriconazole, drug-related adverse symptoms disappeared, and hematocytopenia and the changes in MDS were significantly improved, which was confirmed by a subsequent bone marrow puncture at a 6 months interval.ConclusionThis case reminded us that when using voriconazole for treatment, individual differences in patients should be considered, and the blood concentration of voriconazole should be closely monitored. Otherwise, potential drugs that affect voriconazole metabolism should be noted, and related adverse symptoms of patients should be closely observed during medication to reduce the occurrence of adverse drug events.
    Keywords voriconazole ; myelodysplastic syndrome ; hematocytopenia ; adverse drug reaction ; case report ; systemic lupus erythematosus ; Medicine (General) ; R5-920
    Subject code 616
    Language English
    Publishing date 2023-12-01T00:00:00Z
    Publisher Frontiers Media S.A.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Coproduction of xylooligosaccharides and monosaccharides from hardwood by a combination of acetic acid pretreatment, mechanical refining and enzymatic hydrolysis.

    Su, Yan / Fang, Lingyan / Wang, Peng / Lai, Chenhuan / Huang, Caoxing / Ling, Zhe / Yong, Qiang

    Bioresource technology

    2022  Volume 358, Page(s) 127365

    Abstract: Sequential biorefinery treatments of acetic acid (HAC) pretreatment, Papir Forsknings Institutet (PFI) milling and enzymatic hydrolysis were demonstrated for coproduction of xylooligosaccharides (XOS) and fermentable monosaccharides. Results indicated ... ...

    Abstract Sequential biorefinery treatments of acetic acid (HAC) pretreatment, Papir Forsknings Institutet (PFI) milling and enzymatic hydrolysis were demonstrated for coproduction of xylooligosaccharides (XOS) and fermentable monosaccharides. Results indicated that 36.2% XOS (50.8% X2-X3) and 17.0% low DP xylans were achieved using a HAC pretreatment with a combined severity factor of 0.78. The HAC pretreatment resulted in a XOS-rich prehydrolyzate with a low molecular weight of 1.28 kDa. The endo-xylanase hydrolysis was conducted on the pretreatment liquor to elevate XOS yield and the content of higher-value X2-X3. Moreover, fermentable glucose production from the pretreated residue increased by 2.3 folds when introducing an additional step of PFI refining prior to enzymatic digestion. Properties of substrate including cellulose accessibility, crystallite size, crystalline index and water retention value were in close relationships with enzymatic digestibility. The implementation of proposed biorefinery process will give more insights into the efficient construction of a wood-derived sugar platform.
    MeSH term(s) Acetic Acid ; Glucuronates ; Hydrolysis ; Monosaccharides ; Oligosaccharides ; Xylose
    Chemical Substances Glucuronates ; Monosaccharides ; Oligosaccharides ; xylooligosaccharide ; Xylose (A1TA934AKO) ; Acetic Acid (Q40Q9N063P)
    Language English
    Publishing date 2022-05-23
    Publishing country England
    Document type Journal Article
    ZDB-ID 1065195-0
    ISSN 1873-2976 ; 0960-8524
    ISSN (online) 1873-2976
    ISSN 0960-8524
    DOI 10.1016/j.biortech.2022.127365
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: GSNOR negatively regulates the NLRP3 inflammasome via S-nitrosation of MAPK14.

    Liu, Qianjin / Jiao, Lijin / Ye, Mao-Sen / Ma, Zhiyu / Yu, Jinsong / Su, Ling-Yan / Zou, Wei-Yin / Yang, Lu-Xiu / Chen, Chang / Yao, Yong-Gang

    Cellular & molecular immunology

    2024  

    Abstract: Hyperactivation of the NLRP3 inflammasome has been implicated in the pathogenesis of numerous diseases. However, the precise molecular mechanisms that modulate the transcriptional regulation of NLRP3 remain largely unknown. In this study, we demonstrated ...

    Abstract Hyperactivation of the NLRP3 inflammasome has been implicated in the pathogenesis of numerous diseases. However, the precise molecular mechanisms that modulate the transcriptional regulation of NLRP3 remain largely unknown. In this study, we demonstrated that S-nitrosoglutathione reductase (GSNOR) deficiency in macrophages leads to significant increases in the Nlrp3 and Il-1β expression levels and interleukin-1β (IL-1β) secretion in response to NLRP3 inflammasome stimulation. Furthermore, in vivo experiments utilizing Gsnor
    Language English
    Publishing date 2024-04-03
    Publishing country China
    Document type Journal Article
    ZDB-ID 2435097-7
    ISSN 2042-0226 ; 1672-7681
    ISSN (online) 2042-0226
    ISSN 1672-7681
    DOI 10.1038/s41423-024-01155-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Coproduction of xylooligosaccharides and monosaccharides from hardwood by a combination of acetic acid pretreatment, mechanical refining and enzymatic hydrolysis

    Su, Yan / Fang, Lingyan / Wang, Peng / Lai, Chenhuan / Huang, Caoxing / Ling, Zhe / Yong, Qiang

    Bioresource technology. 2022 May 20,

    2022  

    Abstract: Sequential biorefinery treatments of acetic acid (HAC) pretreatment, Papir Forsknings Institutet (PFI) milling and enzymatic hydrolysis were demonstrated for coproduction of xylooligosaccharides (XOS) and fermentable monosaccharides. Results indicated ... ...

    Abstract Sequential biorefinery treatments of acetic acid (HAC) pretreatment, Papir Forsknings Institutet (PFI) milling and enzymatic hydrolysis were demonstrated for coproduction of xylooligosaccharides (XOS) and fermentable monosaccharides. Results indicated that 36.2% XOS (50.8% X2-X3) and 17.0% low DP xylans were achieved using a HAC pretreatment with a combined severity factor of 0.78. The HAC pretreatment resulted in a XOS-rich prehydrolyzate with a low molecular weight of 1.28 kDa. The endo-xylanase hydrolysis was conducted on the pretreatment liquor to elevate XOS yield and the content of higher-value X2-X3. Moreover, fermentable glucose production from the pretreated residue increased by 2.3 folds when introducing an additional step of PFI refining prior to enzymatic digestion. Properties of substrate including cellulose accessibility, crystallite size, crystalline index and water retention value were in close relationships with enzymatic digestibility. The implementation of proposed biorefinery process will give more insights into the efficient construction of a wood-derived sugar platform.
    Keywords acetic acid ; biorefining ; cellulose ; crystallites ; endo-1,4-beta-xylanase ; enzymatic hydrolysis ; glucose ; hardwood ; hydrolysis ; molecular weight ; xylooligosaccharides
    Language English
    Dates of publication 2022-0520
    Publishing place Elsevier Ltd
    Document type Article
    Note Pre-press version
    ZDB-ID 1065195-0
    ISSN 1873-2976 ; 0960-8524
    ISSN (online) 1873-2976
    ISSN 0960-8524
    DOI 10.1016/j.biortech.2022.127365
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article ; Online: Molecular Mechanism of Neuroprotective Effect of Melatonin on Morphine Addiction and Analgesic Tolerance: an Update.

    Su, Ling-Yan / Liu, Qianjin / Jiao, Lijin / Yao, Yong-Gang

    Molecular neurobiology

    2021  Volume 58, Issue 9, Page(s) 4628–4638

    Abstract: Drug addiction is a global health problem and continues to place an enormous financial burden on society. This addiction is characterized by drug dependence sensitization and craving. Morphine has been widely used for pain relief, but chronic ... ...

    Abstract Drug addiction is a global health problem and continues to place an enormous financial burden on society. This addiction is characterized by drug dependence sensitization and craving. Morphine has been widely used for pain relief, but chronic administration of morphine causes analgesic tolerance, hyperalgesia, and addiction, all of which limit its clinical usage. Alterations of multiple molecular pathways have been reported to be involved in the development of drug addiction, including mitochondrial dysfunction, excessive oxidative stress and nitric oxide stress, and increased levels of apoptosis, autophagy, and neuroinflammation. Preclinical and clinical studies have shown that the co-administration of melatonin with morphine leads to a reversal of these affected pathways. In addition, murine models have shown that melatonin improves morphine-induced analgesic tolerance and addictive behaviors, such as behavioral sensitization, reward effect, and physical dependence. In this review, we attempt to summarize the recent findings about the beneficial effect and molecular mechanism of melatonin on mitochondrial dysfunction, uncontrolled autophagy, and neuroinflammation in morphine addiction and morphine analgesic tolerance. We propose that melatonin might be a useful supplement in the treatment opiate abuse.
    MeSH term(s) Autophagy/drug effects ; Drug Tolerance ; Humans ; Melatonin/pharmacology ; Mitochondria/drug effects ; Morphine/pharmacology ; Morphine Dependence/physiopathology ; Neuroprotective Agents/pharmacology ; Pain Measurement
    Chemical Substances Neuroprotective Agents ; Morphine (76I7G6D29C) ; Melatonin (JL5DK93RCL)
    Language English
    Publishing date 2021-06-19
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 645020-9
    ISSN 1559-1182 ; 0893-7648
    ISSN (online) 1559-1182
    ISSN 0893-7648
    DOI 10.1007/s12035-021-02448-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries.

    Xu, Lingyan / Ling, Jiawei / Su, Chang / Su, Yu-Wen / Xu, Yan / Jiang, Zhenzhou

    Frontiers in medicine

    2021  Volume 8, Page(s) 756435

    Abstract: Indoleamine 2,3-dioxygenase (IDO) is one of the initial rate-limiting enzymes of the kynurenine pathway (KP), which causes immune suppression and induction of T cell anergy. It is associated with the imbalance of immune homeostasis in numerous diseases ... ...

    Abstract Indoleamine 2,3-dioxygenase (IDO) is one of the initial rate-limiting enzymes of the kynurenine pathway (KP), which causes immune suppression and induction of T cell anergy. It is associated with the imbalance of immune homeostasis in numerous diseases including cancer, chronic viral infection, allergy, and autoimmune diseases. Recently, IDO has extended its role to liver field. In this review, we summarize the dysregulation and potentials of IDO in the emerging field of liver injuries, as well as current challenges for IDO targets. In particular, we discuss unexpected conclusions against previous work published. IDO is induced by pro-inflammatory cytokines in liver dysfunction and exerts an immunosuppressive effect, whereas the improvement of liver injury may require consideration of multiple factors besides IDO.
    Language English
    Publishing date 2021-11-18
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2021.756435
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Co-production of xylooligosaccharides and glucose from birch sawdust by hot water pretreatment and enzymatic hydrolysis

    Fang, Lingyan / Su, Yan / Wang, Peng / Lai, Chenhuan / Huang, Caoxing / Ling, Zhe / Yong, Qiang

    Bioresource technology. 2022 Mar., v. 348

    2022  

    Abstract: A green method for co-production of value-added xylooligosaccharides (XOS) and glucose from birch was demonstrated using hot water pretreatment. Effects of pretreatment severity factor (Log R₀) on XOS production and enzymatic hydrolysis were investigated. ...

    Abstract A green method for co-production of value-added xylooligosaccharides (XOS) and glucose from birch was demonstrated using hot water pretreatment. Effects of pretreatment severity factor (Log R₀) on XOS production and enzymatic hydrolysis were investigated. At Log R₀ of 4.05 (180 °C, 50 min), the maximum hydrolysis yield (80.8%) was obtained. At Log R₀ of 3.91 (170 °C, 70 min), the maximum XOS yield (46.1%) was obtained, however the hydrolysis yield decreased to 70.3%. To achieve both the high XOS yield and high glucose output, Tween 80 addition (0.075 g/g cellulose) was employed, leading to an improvement in hydrolysis yield from 70.3% to 89.4%. From a mass balance perspective, 104.6 g of XOS and 372.9 g of glucose could be produced from 1000 g birch. These results demonstrated that birch sawdust is a promising lignocellulosic material for co-production of XOS and glucose.
    Keywords Betula ; cellulose ; enzymatic hydrolysis ; glucose ; hydrolysis ; lignocellulose ; polysorbates ; sawdust ; technology ; value added ; xylooligosaccharides
    Language English
    Dates of publication 2022-03
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 1065195-0
    ISSN 1873-2976 ; 0960-8524
    ISSN (online) 1873-2976
    ISSN 0960-8524
    DOI 10.1016/j.biortech.2022.126795
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top